5-amino-1mq subcutaneous injection dose What Is 5-Amino-1MQ? How It Works (And Why Most Dosing Is Wrong) 3 Simple Ways to Lose

Capsule format ensures accuracy, making dosing simple for lab studies

Why was AOD-9604 discontinued as a commercial drug if it showed promise

A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity

It is not intended for diagnostic, therapeutic, or clinical applications

We are not currently accepting new orders

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut